期刊文献+

氨茶碱与肾上腺素联合在小儿心肺复苏中的应用价值研究 被引量:4

原文传递
导出
摘要 目的 探讨氨茶碱与肾上腺素联合应用在小儿心肺复苏中的应用效果及临床价值。方法 214例1~14岁心跳骤停(CA)患者随机分成三组,即标准肾上腺素剂量对照组(SDE组)72例、大剂量肾上腺素组(眦组)68例、氨茶碱与肾上腺素联合应用组(ADE组)74例。CA后立即按国际标准规定心肺复苏流程行胸外心脏按压及建立人工气道基础上快速采用肘静脉通道给予:(1)SDE组采用0.02mg/kg首次剂量肾上腺索静推,无效后每间隔3min重复。(2)HDE组,采用0.1mg/kg肾上腺素首次剂量,无效后每间隔3min重复。(3)ADE组,采用氨茶碱10mg/kg和肾上腺素0.02mg/kg,作为首次剂量静脉推注,若无效后,每间隔3min重复,同时进行心电、平均动脉压(MAP)、心率(HR)、自主循环恢复(眦)的时间等监测和复苏效果评价。结果 (1)ADE组和HDE组自主循环恢复率、24h存活率、出院存活率、出院存活Glasgow昏迷评分与SDE对照组比较差异有高度统计学意义(P〈0.01)。(2)AnF组与HDE组比较,ADE组用肾上腺素总量明显比HDE组减少,但自主循环恢复率、24h存活率、出院存活率明显升高(P〈0,05)。结论 氨茶碱和肾上腺素联用能明显提高心肺复苏自主循环恢复率、24h存活率、出院存活率,是提高小儿心肺脑复苏成功率新的方法和途径。
出处 《中国医师进修杂志》 2006年第1期43-45,47,共4页 Chinese Journal of Postgraduates of Medicine
  • 引文网络
  • 相关文献

参考文献8

二级参考文献37

  • 1Vinten JJ,Thourani VH,Ronson RS,et al.Broad-spectrum cardioprotection with adenosine.Ann Thorac Surg,1999,68(5):1942-1948.
  • 2Frishman WH,Vahdat S,Bhatta S.Innovative pharmacologic approaches to cardiopulmonary resuscitation.J Clin Pharmacol ,1998,38(9):765-772.
  • 3Paradis NA,Martin GB,Rosenberg J,et al.The effect of standard-and high-dose epinephrine oncoronary perfusion pressure during prolonged cardiopulmonary resuscitation.JAMA,1991,265(9):1139.
  • 4Mader TJ,Gibson P.Adenosine receptor antagonism in refractory asystolic cardiac arrest:results of a human pilot study.Resuscitation.1997,35 (1):3-7.
  • 5Hendrickx AHL,Rao GR,Safar P,et al.Asphyxia,cardiac arrest and resuscitation in rats.Resuscitation,1984,12(2):97-116.
  • 6Menegazzi JJ,Seabert DC,Yealy DM,et al.Combination pharmacotherapy with delayed countershock vs.standard advanced cardiac life support after prolonged ventricular fibrillation.Pre Emerg Care,2000,4(1):31-37.
  • 7Omato JP,Peberdy MA.Etiology,electrophysiology and myocardial mechanics of bradyasystolic states.In:Paradis NA,Halperin HR,Nowak RM,eds.Cardiac Arrest:The Science and Practice of Resuscitation Medicine.Baltimore:Williams & Wilkins,1996 .338-352.
  • 8Belardinelli L,Linden J,Berne RM.The cardiac effects of adenosine.Prog Cardiovasc Res,1989,32(1):73-97.
  • 9Lcrman BB,Engelstein ED.Metabolic Determinants of Defibrillation.Circulation,1995,91(4):838-844.
  • 10Viskin S,Belhassen B,Roth A,et al.Aminophylline for bradyasystolic cardiac arrest refractory to atropine and epinephrine.Ann Intern Med,1993,118(2):279-281.

共引文献86

同被引文献29

引证文献4

二级引证文献11

;
使用帮助 返回顶部